Yeah, ok. How about you google the Regeneron/Sanofi deal and see how that series of deals was structured. Regeneron reduced its risk tremendously and is enjoying nice fat revenue streams and a guaranteed partner for all future product development. Mannkind will also benefit from such relationship and now is freed up to bring future product and technology to the market. Sanofi is screaming for new product patent lines. Mannkind has cash in the bank (no dilution) and will lower expenses over future quarters.
Keep shorting. Wait a few quarters from now and eat your words. And don't forget that a buyout is always lurking. You'll wake up one day and find out that you owe your retirement fund to your mistake.
If you actually follow the company's progress, Afrezza is just a piece of their R&D portfolio. They are developing other marketable solutions and let's not forget their technosphere solutions which are highly in demand. There is nothing in this agreement that prevents MNKD from being bought out. In fact, this is just another awesome development in the company's success. Sharing the risk and reward is one of Al's best moves.
If you buy now, you should see $15-20/PPS in short order. Get greedy for the 50-100% short term gains. Afrezza is going to market and Mannkind will collect on every turn. I wouldn't be surprised if Sanofi doesn't make an offer for $60/share.
Sanofi could move in on Mannkind at this low pps. They bought big into Regeneron but did not acquire once Regeneron share price soared. Regeneron got a sweetheart deal in a 50/50 profit share and Sanofi picking up all costs. Mannkind could see a similar type deal in the future if they aren't bought out first. I do agree that the stock price will start going up steadily. I figure $100/share in a year or two. Sanofi needs to get afrezza into the marketplace soon to meet their 2015 product goal.
This is not good for shorts. They will catapult the share price more quickly once they realize their greedy mistake.
Restate - Sanofi makes an offer for $60/share. A year from now I think buyout offers will be coming in much higher.
I'd rather the company follow in the steps of Regeneron. That stock was trading at $15/share five years ago and now it's hovering around $340. I can hold my several thousand shares for awhile in anticipation of a nice ride up. Of course, the company will need to be showing double digit yoy quarterly growth which it should do as the rest of its pipeline and technology is brought to market.
Intermune was bought out and those investors cashed out when I think the company could've kept growing on its own. For sure it was a nice buyout price but they were breaking into a solid ride up and now the company belongs to Roche.
I think the company will trade in the $7-13 range until early next year as they get the cash infusion in place and towards building out the execution plan. Once they start showing revenue, the price will start rising. As new products are brought to market and realizing revenue, watch out!!
Nope. I am what they call a warlock. You will never understand what I see in the future. I see exactly where this company will be in the future. A gift that most never will ever achieve. Good luck to you.
Cramer paid homage to Al Mann. "I can only say that Al Mann exceeded my expectations". Go on the MNKD board for the CNBC link. It is classic.
Ariad will get bought out. The price is probably around $40/share offer but I think with a little more patience they can get $70/share. Boooyaahhhh.
What a schmuck you are.....you none Germanic. You do understand that the spiritual rule this world, right? $200 million loan.....laughable. The buyout will happen and it will be between $30 and $40. Go contest it to the Unholy.....jerk boy.
Yes! And thankfully MNKD told Pfizer to take a hike. Those Pfizer folks can take their old inventory and sell them as bongs to third world countries. Lol.
It would be great for the short hedgies to drop the price down further so I can scoop up more shares and tuck them away with a $300 sell limit. At a $1 per share, I will be counting my tens of millions in a few years. What a blessing that would be.